Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 04/25/24
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & DevelopmentGlobeNewsWire • 03/29/24
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCCGlobeNewsWire • 11/17/23
U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The PipelineSeeking Alpha • 09/30/23
U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical DevicesSeeking Alpha • 08/12/23